Recent changes in breast cancer incidence and risk factor prevalence in San Francisco Bay area and California women: 1988 to 2004
- PMID: 20210979
- PMCID: PMC2829782
- DOI: 10.1186/bcr1768
Recent changes in breast cancer incidence and risk factor prevalence in San Francisco Bay area and California women: 1988 to 2004
Abstract
Introduction: Historically, the incidence rate of breast cancer among non-Hispanic white women living in the San Francisco Bay area (SFBA) of California has been among the highest in the world. Substantial declines in breast cancer incidence rates have been documented in the United States and elsewhere during recent years. In light of these reports, we examined recent changes in breast cancer incidence and risk factor prevalence among non-Hispanic white women in the SFBA and other regions of California.
Methods: Annual age-adjusted breast cancer incidence and mortality rates (1988 to 2004) were obtained from the California Cancer Registry and analyzed using Joinpoint regression. Population-based risk factor prevalences were calculated using two data sources: control subjects from four case-control studies (1989 to 1999) and the 2001 and 2003 California Health Interview Surveys.
Results: In the SFBA, incidence rates of invasive breast cancer increased 1.3% per year (95% confidence interval [CI], 0.7% to 2.0%) in 1988-1999 and decreased 3.6% per year (95% CI, 1.6% to 5.6%) in 1999-2004. In other regions of California, incidence rates of invasive breast cancer increased 0.8% per year (95% CI, 0.4% to 1.1%) in 1988-2001 and decreased 4.4% per year (95% CI, 1.4% to 7.3%) in 2001-2004. In both regions, recent (2000-2001 to 2003-2004) decreases in invasive breast cancer occurred only in women 40 years old or older and in women with all histologic subtypes and tumor sizes, hormone receptor-defined types, and all stages except distant disease. Mortality rates declined 2.2% per year (95% CI, 1.8% to 2.6%) from 1988 to 2004 in the SFBA and the rest of California. Use of estrogen-progestin hormone therapy decreased significantly from 2001 to 2003 in both regions. In 2003-2004, invasive breast cancer incidence remained higher (4.2%) in the SFBA than in the rest of California, consistent with the higher distributions of many established risk factors, including advanced education, nulliparity, late age at first birth, and alcohol consumption.
Conclusion: Ongoing surveillance of breast cancer occurrence patterns in this high-risk population informs breast cancer etiology through comparison of trends with lower-risk populations and by highlighting the importance of examining how broad migration patterns influence the geographic distribution of risk factors.
Figures



Similar articles
-
Regional differences in known risk factors and the higher incidence of breast cancer in San Francisco.J Natl Cancer Inst. 1997 Jul 2;89(13):960-5. doi: 10.1093/jnci/89.13.960. J Natl Cancer Inst. 1997. PMID: 9214676
-
Regional variations in breast cancer incidence among California women, 1988-1997.Cancer Causes Control. 2005 Mar;16(2):139-50. doi: 10.1007/s10552-004-2616-5. Cancer Causes Control. 2005. PMID: 15868455
-
Breast cancer incidence and mortality trends in an affluent population: Marin County, California, USA, 1990-1999.Breast Cancer Res. 2002;4(6):R13. doi: 10.1186/bcr458. Epub 2002 Jul 26. Breast Cancer Res. 2002. PMID: 12473174 Free PMC article.
-
Geographic excess of estrogen receptor-positive breast cancer.Cancer Epidemiol Biomarkers Prev. 2003 Dec;12(12):1523-7. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 14693747
-
Trends in hormone therapy and breast cancer incidence - results from the German Network of Cancer Registries.Pathobiology. 2009;76(2):90-7. doi: 10.1159/000201677. Epub 2009 Apr 9. Pathobiology. 2009. PMID: 19367129 Review.
Cited by
-
Prevalence of breast cancer in a defined population of iran.Iran Red Crescent Med J. 2011 Sep;13(9):647-50. doi: 10.5812/kowsar.20741804.2245. Epub 2011 Sep 15. Iran Red Crescent Med J. 2011. PMID: 22737539 Free PMC article.
-
Decline in hormone replacement prescription and fall in breast cancer incidence: an epidemiological discourse.Dtsch Arztebl Int. 2008 Apr;105(16):303-9. doi: 10.3238/arztebl.2008.0303. Epub 2008 Apr 18. Dtsch Arztebl Int. 2008. PMID: 19629226 Free PMC article.
-
KRAS Gene Polymorphisms and their Impact on Breast Cancer Risk in an Iranian Population.Asian Pac J Cancer Prev. 2017 May 1;18(5):1301-1305. doi: 10.22034/APJCP.2017.18.5.1301. Asian Pac J Cancer Prev. 2017. PMID: 28610418 Free PMC article.
-
Breast Carcinoma Receptor Expression in a Caribbean Population.Surg J (N Y). 2022 Sep 19;8(3):e262-e265. doi: 10.1055/s-0042-1756632. eCollection 2022 Jul. Surg J (N Y). 2022. PMID: 36131945 Free PMC article.
-
A Population-Based Observational Study of First-Course Treatment and Survival for Adolescent and Young Adult Females with Breast Cancer.J Adolesc Young Adult Oncol. 2013 Sep;2(3):95-103. doi: 10.1089/jayao.2013.0004. J Adolesc Young Adult Oncol. 2013. PMID: 24066271 Free PMC article.
References
-
- Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB, (Eds) Cancer Incidence in Five Continents, Vol. VIII, Vol. 155. Lyon, France: IARC Scientific Publications; 2002.
-
- State Cancer Profiles. http://statecancerprofiles.cancer.gov/